Expression of S100, HMB45 and Melan A in Oral Mucosal Melanoma
نویسندگان
چکیده
منابع مشابه
Immunohistochemical expression of melan-A and tyrosinase in uveal melanoma
BACKGROUND Melan-A and tyrosinase are new immunohistochemical markers that can be used in the diagnosis of melanocytic lesions. The aim of this study was to investigate the correlation between radiotherapy or clinicohistopathological parameters and the expression of melan-A and tyrosinase in uveal melanoma. METHODS Thirty-six enucleated cases of uveal melanoma were studied. The formalin-fixed...
متن کاملOral mucosal melanoma: a malignant trap
Oral mucosal melanomas are highly malignant tumors. The 'chameleonic' presentation of a mainly asymptomatic condition, the rarity of these lesions, the poor prognosis and the necessity of a highly specialized treatment are factors that should be seriously considered by the involved health provider. We present the case of a 75-year-old man who was referred to the Ear, Nose and Throat department....
متن کاملPrognostic value of S100/CD31 and S100/podoplanin double immunostaining in mucosal malignant melanoma of the head and neck.
BACKGROUND In uncommon mucosal melanomas of the head and neck established prognostic factors are rare and controversially discussed. The purpose of this study was to evaluate outcome and value of S100/podoplanin and S100/CD31 double immunostaining in head and neck mucosal melanomas. METHODS Retrospectively, patients with head and neck mucosal melanomas treated between 1973 and 2008 were analy...
متن کاملHeparanase and vascular endothelial growth factor expression in the progression of oral mucosal melanoma.
Oral mucosal melanoma is an aggressive neoplasm with poor prognosis. Heparanase is an endo-beta-d-glucuronidase, which cleaves heparan sulphate chains. The vascular endothelial growth factor (VEGF) is the most potent angiogenic mitogen and interaction with its receptor (VEGFR) has been associated with angiogenesis. We investigated the expression of these molecules in the progression of oral muc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Pharmaceutical Research International
سال: 2021
ISSN: 2456-9119
DOI: 10.9734/jpri/2021/v33i32a31719